![Feng Lin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Lin
Hoofd Techniek/Wetenschap/O&O bij THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Vermogen: 62 000 $ op 31-05-2024
Profiel
Feng Lin is currently the Chief Scientific Officer at Therapeutic Solutions International, Inc. He previously worked as the Director of Chinese Operations at Medistem, Inc. from 2012 to 2014, Senior Scientist at Inovio Pharmaceuticals, Inc. from 2007 to 2012, and Associate at Sanford Burnham Prebys Medical Discovery Institute from 1999 to 2005.
He was also the Chief Scientific Officer at SuperView Biotechnology Co. Ltd.
from 2014 to 2019.
Dr. Lin has a doctorate degree from Central South University, which he received in 1998, as well as a graduate degree and an undergraduate degree from the same university, which he received in 1994 and 1990, respectively.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-12-2023 | 62 000 000 ( 1.47% ) | 62 000 $ | 31-05-2024 |
Actieve functies van Feng Lin
Bedrijven | Functie | Begin |
---|---|---|
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Hoofd Techniek/Wetenschap/O&O | 03-09-2019 |
Eerdere bekende functies van Feng Lin
Bedrijven | Functie | Einde |
---|---|---|
SuperView Biotechnology Co. Ltd. | Hoofd Techniek/Wetenschap/O&O | 01-08-2019 |
MEDISTEM INC | Corporate Officer/Principal | 01-05-2014 |
INOVIO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2012 |
Sanford Burnham Prebys Medical Discovery Institute
![]() Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01-12-2005 |
RIVULET MEDIA, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Feng Lin
Central South University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
INOVIO PHARMACEUTICALS, INC. | Health Technology |
RIVULET MEDIA, INC. | Technology Services |
ENTEST GROUP, INC. | Finance |
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Medistem, Inc.
![]() Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Sanford Burnham Prebys Medical Discovery Institute
![]() Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
SuperView Biotechnology Co. Ltd. |